Evidence map›Paper›PMID 35508583›Full record

ArticleScientific reports2022

A systems approach discovers the role and characteristics of seven LysR type transcription factors in Escherichia coli.

Irina A Rodionova, Ye Gao, Jonathan Monk, Ying Hefner, Nicholas Wong, Richard Szubin, Hyun Gyu Lim, Dmitry A Rodionov, Zhongge Zhang, Milton H Saier and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Antagonistic Interactions BetweenInternational journal of molecular sciences · 2025
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Synthetic biology (Oxford, England) · 2024
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Irina A Rodionova *Department of Bioengineering, University of California San Diego, La Jolla, CA, 92093-0116, USA. irodionova@ucsd.edu.
Ye Gao *Department of Bioengineering, University of California San Diego, La Jolla, CA, 92093-0116, USA.
Jonathan MonkDepartment of Bioengineering, University of California San Diego, La Jolla, CA, 92093-0116, USA.
Ying HefnerDepartment of Bioengineering, University of California San Diego, La Jolla, CA, 92093-0116, USA.
Nicholas WongDivision of Biological Sciences, Department of Molecular Biology, University of California San Diego, La Jolla, CA, 92093-0116, USA.
Richard SzubinDepartment of Bioengineering, University of California San Diego, La Jolla, CA, 92093-0116, USA.
Hyun Gyu LimDepartment of Bioengineering, University of California San Diego, La Jolla, CA, 92093-0116, USA.
Dmitry A RodionovSanford-Burnham-Prebys Medical Discovery Institute, La Jolla, CA, 92037, USA.
Zhongge ZhangDivision of Biological Sciences, Department of Molecular Biology, University of California San Diego, La Jolla, CA, 92093-0116, USA.
Milton H SaierDivision of Biological Sciences, Department of Molecular Biology, University of California San Diego, La Jolla, CA, 92093-0116, USA.
Bernhard O PalssonDepartment of Bioengineering, University of California San Diego, La Jolla, CA, 92093-0116, USA. palsson@ucsd.edu.

Funding

Systems Biology Approach to Redefine Susceptibility Testing and Treatment of MDR Pathogens in the Context of Host ImmunityU01AI124316 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI PALSSON, BERNHARD O · 2016 to 2020
$10.2M
The Transporter Classification Database (TCDB)R01GM077402 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SAIER, MILTON H. · 2006 to 2021
$4.7M
NIAID NIH HHS U01 AI124316NIGMS NIH HHS R01 GM077402NIH HHS U01AI124316
6 · The paper itself

Abstract

Although Escherichia coli K-12 strains represent perhaps the best known model bacteria, we do not know the identity or functions of all of their transcription factors (TFs). It is now possible to systematically discover the physiological function of TFs in E. coli BW25113 using a set of synergistic methods; including ChIP-exo, growth phenotyping, conserved gene clustering, and transcriptome analysis. Among 47 LysR-type TFs (LTFs) found on the E. coli K-12 genome, many regulate nitrogen source utilization or amino acid metabolism. However, 19 LTFs remain unknown. In this study, we elucidated the regulation of seven of these 19 LTFs: YbdO, YbeF, YcaN, YbhD, YgfI, YiaU, YneJ. We show that: (1) YbdO (tentatively re-named CitR) regulation has an effect on bacterial growth at low pH with citrate supplementation. CitR is a repressor of the ybdNM operon and is implicated in the regulation of citrate lyase genes (citCDEFG); (2) YgfI (tentatively re-named DhfA) activates the dhaKLM operon that encodes the phosphotransferase system, DhfA is involved in formate, glycerol and dihydroxyacetone utilization; (3) YiaU (tentatively re-named LpsR) regulates the yiaT gene encoding an outer membrane protein, and waaPSBOJYZU operon is also important in determining cell density at the stationary phase and resistance to oxacillin microaerobically; (4) YneJ, re-named here as PtrR, directly regulates the expression of the succinate-semialdehyde dehydrogenase, Sad (also known as YneI), and is a predicted regulator of fnrS (a small RNA molecule). PtrR is important for bacterial growth in the presence of L-glutamate and putrescine as nitrogen/energy sources; and (5) YbhD and YcaN regulate adjacent y-genes on the genome. We have thus established the functions for four LTFs and identified the target genes for three LTFs.

Indexed as

Escherichia coli K12Escherichia coli ProteinsBacterial ProteinsEscherichia coliGene Expression Regulation, BacterialNitrogenOperonSystems AnalysisTranscription FactorsBacterial ProteinsEscherichia coli ProteinsNitrogenTranscription Factors

Identifiers

PMID35508583
PMCPMC9068703

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.